- Home
- RCUS vs CLMT Comparison
RCUS vs CLMT Comparison
Compare RCUS & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | CLMT |
|---|---|---|
| Founded | 2015 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 1.8B |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | RCUS | CLMT |
|---|---|---|
| Price | $22.95 | $19.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $29.38 | $20.45 |
| AVG Volume (30 Days) | ★ 2.1M | 569.6K |
| Earning Date | 10-28-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $240,000,000.00 | ★ $4,048,000,000.00 |
| Revenue This Year | N/A | $0.23 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.50 | $7.68 |
| 52 Week High | $26.40 | $23.75 |
Technical Indicators
Market Signals| Indicator | RCUS | CLMT |
|---|---|---|
| Relative Strength Index (RSI) | 52.09 | 54.34 |
| Support Level | $21.80 | $19.51 |
| Resistance Level | $23.62 | $20.02 |
| Average True Range (ATR) | 1.13 | 0.58 |
| MACD | -0.22 | -0.03 |
| Stochastic Oscillator | 46.70 | 39.71 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About CLMT Calumet Specialty Products Partners L.P.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.